• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑及血脑屏障中胰岛素样生长因子-I和-II(IGF-I和-II)受体的显示及结构比较

Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.

作者信息

Rosenfeld R G, Pham H, Keller B T, Borchardt R T, Pardridge W M

机构信息

Department of Pediatrics, Stanford University Medical Center, California 94305.

出版信息

Biochem Biophys Res Commun. 1987 Nov 30;149(1):159-66. doi: 10.1016/0006-291x(87)91618-4.

DOI:10.1016/0006-291x(87)91618-4
PMID:2961336
Abstract

Specific receptors for insulin-like growth factors (IGF) I and II on microvessel-free rat brain cell membranes (RBCM) and in the microvessels that constitute the blood-brain barrier (BBB) were identified and characterized by means of affinity cross-linking techniques and specific anti-receptor antibodies. Two different models of BBB were examined: isolated rat brain capillaries and cultured bovine brain microvessel endothelial cells. Cross-linking with 125-I-IGF-I, followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), revealed an alpha subunit of apparent Mr = 138,000 in both BBB preparations, compared to 120,000 in RBCM. Cross-linking was inhibited by unlabeled IGF and insulin, but not by antibody directed against the IGF-II receptor. When 125-I-IGF-II was cross-linked, followed by SDS-PAGE under reducing conditions, a major band of apparent Mr = 250,000 was identified in RBCM and both BBB preparations. This band, which migrated with an approximately equivalent Mr in both brain and BBB membranes, was inhibited by unlabeled IGF and by antibody specific for the IGF-II receptor. Thus, both rat and bovine brain microvessels possess classical Type I and II IGF receptors. While the alpha subunit of the Type I receptor of brain is smaller than that of the BBB, the Type II receptor of brain and BBB appear to be structurally and immunologically identical.

摘要

利用亲和交联技术和特异性抗受体抗体,对无微血管的大鼠脑细胞膜(RBCM)以及构成血脑屏障(BBB)的微血管中胰岛素样生长因子(IGF)Ⅰ和Ⅱ的特异性受体进行了鉴定和特性分析。研究了两种不同的血脑屏障模型:分离的大鼠脑毛细血管和培养的牛脑微血管内皮细胞。用¹²⁵I-IGF-Ⅰ进行交联,随后进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE),结果显示,在两种血脑屏障制剂中均出现一条表观分子量为138,000的α亚基,而在RBCM中为120,000。未标记的IGF和胰岛素可抑制交联反应,但针对IGF-Ⅱ受体的抗体则无此作用。当用¹²⁵I-IGF-Ⅱ进行交联,随后在还原条件下进行SDS-PAGE时,在RBCM和两种血脑屏障制剂中均鉴定出一条表观分子量为250,000的主要条带。这条在脑和血脑屏障膜中迁移时具有大致相同分子量的条带,可被未标记的IGF和针对IGF-Ⅱ受体的特异性抗体所抑制。因此,大鼠和牛脑微血管均具有经典的Ⅰ型和Ⅱ型IGF受体。虽然脑Ⅰ型受体的α亚基比血脑屏障的小,但脑和血脑屏障的Ⅱ型受体在结构和免疫方面似乎是相同的。

相似文献

1
Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.脑及血脑屏障中胰岛素样生长因子-I和-II(IGF-I和-II)受体的显示及结构比较
Biochem Biophys Res Commun. 1987 Nov 30;149(1):159-66. doi: 10.1016/0006-291x(87)91618-4.
2
Structural and immunohistochemical characterization of insulin-like growth factor I and II receptors in the murine central nervous system.小鼠中枢神经系统中胰岛素样生长因子I和II受体的结构与免疫组织化学特征
Endocrinology. 1988 Aug;123(2):1023-34. doi: 10.1210/endo-123-2-1023.
3
Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels.分离的脑微血管对胰岛素及胰岛素样生长因子的结合与内化作用
Diabetes. 1986 Jun;35(6):654-61. doi: 10.2337/diab.35.6.654.
4
Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.人乳腺癌细胞系中胰岛素样生长因子(IGF-I和-II)受体及结合蛋白的展示
Biochem Biophys Res Commun. 1988 Apr 15;152(1):398-405. doi: 10.1016/s0006-291x(88)80727-7.
5
Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.可溶性34K结合蛋白抑制胰岛素样生长因子I与其在人分泌期子宫内膜细胞受体的结合:生长因子作用自分泌/旁分泌调节的证据。
J Clin Endocrinol Metab. 1988 Jan;66(1):173-80. doi: 10.1210/jcem-66-1-173.
6
Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.克隆大鼠垂体瘤细胞上的胰岛素及胰岛素样生长因子(生长调节素)受体
Endocrinology. 1985 Nov;117(5):2008-16. doi: 10.1210/endo-117-5-2008.
7
Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.牛生长板软骨细胞上I型和II型生长调节素受体的证实
J Orthop Res. 1988;6(6):817-26. doi: 10.1002/jor.1100060605.
8
Characterization of somatomedin/insulin-like growth factor receptors and correlation with biologic action in cultured neonatal rat astroglial cells.新生大鼠培养星形胶质细胞中生长调节素/胰岛素样生长因子受体的特性及其与生物学活性的相关性
J Neurosci. 1987 Feb;7(2):501-11. doi: 10.1523/JNEUROSCI.07-02-00501.1987.
9
Specific, high affinity receptors for insulin-like growth factor II in the rat kidney glomerulus.大鼠肾小球中胰岛素样生长因子II的特异性高亲和力受体。
Endocrinology. 1988 Aug;123(2):774-80. doi: 10.1210/endo-123-2-774.
10
Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.大鼠神经母细胞瘤细胞中的胰岛素样生长因子受体和结合蛋白
Endocrinology. 1989 Jan;124(1):388-96. doi: 10.1210/endo-124-1-388.

引用本文的文献

1
Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis.体轴对脑血管衰老过程的非自主调控。
Front Endocrinol (Lausanne). 2023 Jan 23;14:1087053. doi: 10.3389/fendo.2023.1087053. eCollection 2023.
2
Evidence for an alternative insulin transporter at the blood-brain barrier.血脑屏障处存在另一种胰岛素转运体的证据。
Aging Pathobiol Ther. 2022;4(4):100-108. doi: 10.31491/apt.2022.12.100. Epub 2022 Dec 29.
3
Insulin-Like Growth Factor-2 (IGF-2) Does Not Improve Memory in the Chronic Stage of Traumatic Brain Injury in Rodents.
胰岛素样生长因子2(IGF-2)不能改善啮齿动物创伤性脑损伤慢性期的记忆。
Neurotrauma Rep. 2021 Oct 20;2(1):453-460. doi: 10.1089/neur.2021.0031. eCollection 2021.
4
Enhancement of memories by systemic administration of insulin-like growth factor II.通过全身注射胰岛素样生长因子II增强记忆。
Neuropsychopharmacology. 2014 Aug;39(9):2179-90. doi: 10.1038/npp.2014.69. Epub 2014 Mar 19.
5
Human conditions of insulin-like growth factor-I (IGF-I) deficiency.胰岛素样生长因子-I(IGF-I)缺乏的人体状况。
J Transl Med. 2012 Nov 14;10:224. doi: 10.1186/1479-5876-10-224.
6
Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.发育调控的甘露糖6-磷酸受体介导的溶酶体酶穿越血脑屏障的转运。
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12658-63. doi: 10.1073/pnas.0405042101. Epub 2004 Aug 16.
7
The role of the insulin-like growth factors in the central nervous system.胰岛素样生长因子在中枢神经系统中的作用。
Mol Neurobiol. 1996 Dec;13(3):227-55. doi: 10.1007/BF02740625.
8
Macromolecular permeability across the blood-nerve and blood-brain barriers.大分子透过血神经屏障和血脑屏障的情况。
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5705-9. doi: 10.1073/pnas.91.12.5705.
9
Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.胰岛素样生长因子I治疗可减轻实验性自身免疫性脑脊髓炎中的脱髓鞘现象,并上调髓鞘相关蛋白的基因表达。
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6190-4. doi: 10.1073/pnas.92.13.6190.
10
Insulin and insulin-like growth factor receptors in the nervous system.神经系统中的胰岛素及胰岛素样生长因子受体
Mol Neurobiol. 1989 Spring-Summer;3(1-2):71-100. doi: 10.1007/BF02935589.